D&D Pharmatech Inc. (KOSDAQ:347850)
33,900
-3,500 (-9.36%)
Nov 20, 2026, 3:30 PM KST
D&D Pharmatech Market Cap
D&D Pharmatech has a market cap or net worth of 1.55 trillion as of November 20, 2026. It is the 8,755th most valuable company in the world and the 215th biggest in South Korea. Its market cap has decreased by 60.37% in one year.
Market Cap
1.55T
Enterprise Value
1.52T
Revenue
2.75B
Global Rank
Country Rank
#215 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since May 2, 2024, D&D Pharmatech's market cap has increased from 379.56B to 1.55T, an increase of 309.39%. That is a compound annual growth rate of 73.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 1.55T | -61.12% |
| Dec 30, 2025 | 4.00T | 678.13% |
| Dec 30, 2024 | 513.61B | 35.32% |
| May 2, 2024 | 379.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HLB Co., Ltd. | 3.64T |
| SK bioscience | 3.00T |
| Hugel | 2.29T |
| Peptron | 2.05T |
| ABL Bio | 2.00T |
| LigaChem Biosciences | 1.95T |
| Voronoi | 1.93T |
| OliX Pharmaceuticals | 1.78T |